OTC - ACTIVE INGREDIENT SECTION
titanium dioxide
titanium dioxide
water, glycerin, zinc oxide, bentonite, sodium chloride, butylene glycol, disodium edta, fragrance, etc
protect the skin againse the harmful UV rays
keep out or reach of the children
apply evenly on exposed areas after daily skin-care routine
-If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately
-This product is for exeternal use only. Do not use for internal use
-If possible, avoid direct sunlight and store in cool and area of low humidity
-In order to maintain the quality of the product and avoid misuse
-Avoid placing the product near fire and store out in reach of children
for external use only
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69327-3001-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0cfd-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69327-3001-1 | Fikia Marine Eclipse Sun Block SPF 50 PA | 40 mL in 1 TUBE | CREAM | 40 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69327-3001 | FIKIA MARINE ECLIPSE SUN BLOCK SPF 50 PA (TITANIUM DIOXIDE) CREAM [BEAUTY LINE CO., LTD.] | 1 | Legacy NDC, 1 package rows | 20141026_2ec3113d-2c1d-4d7a-85bb-b0f16c1017be.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69327-3001 | 69327-3001-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
| WATER | 059QF0KO0R | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| HYALURONATE SODIUM | YSE9PPT4TH | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 89348ef4-5656-49ee-8ce6-17e609259c5c | 2ec3113d-2c1d-4d7a-85bb-b0f16c1017be | 2014-10-25 | Warnings | 89348ef4-5656-49ee-8ce6-17e609259c5c 2ec3113d-2c1d-4d7a-85bb-b0f16c1017be |
Adverse event summaries are temporarily unavailable. Other product information remains available.